Urinary biomarkers to predict acute kidney damage and mortality in COVID-19
Clinical Nephrology · 01.04.2023 · 99 (4) · 161-171
DOI: 10.5414/cn110952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nephrology, erschienen am 01.04.2023. Verfasst von Diana Racovitan und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, Acute Kidney Injury, Ureteral Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Racovitan, D., Hogeweg, M., Doevelaar, A. A., Seidel, M., Rohn, B., Bettag, S., Rieckmann, S., Babel, N., Seibert, F. S., & Westhoff, T. H. (2023). Urinary biomarkers to predict acute kidney damage and mortality in COVID-19. Clinical Nephrology, 99(4), 161-171. https://doi.org/10.5414/cn110952
Vancouver
Racovitan D, Hogeweg M, Doevelaar AA, Seidel M, Rohn B, Bettag S, et al. Urinary biomarkers to predict acute kidney damage and mortality in COVID-19. Clinical Nephrology. 2023;99(4):161-171. doi:10.5414/cn110952
BibTeX
@article{Racovitan2023,
author = {Racovitan, Diana and Hogeweg, Maximilian and Doevelaar, Adrian A and Seidel, Maximilian and Rohn, Benjamin and Bettag, Sebastian and Rieckmann, Sonja and Babel, Nina and Seibert, Felix S and Westhoff, Timm H},
title = {Urinary biomarkers to predict acute kidney damage and mortality in COVID-19},
journal = {Clinical Nephrology},
year = {2023},
volume = {99},
number = {4},
pages = {161--171},
doi = {10.5414/cn110952}
}
EUVIMED